GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Eusol Biotech Co Ltd (ROCO:6652) » Definitions » Market Cap

Eusol Biotech Co (ROCO:6652) Market Cap : NT$1,217.93 Mil (As of Jun. 05, 2024)


View and export this data going back to 2018. Start your Free Trial

What is Eusol Biotech Co Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Eusol Biotech Co's share price for the quarter that ended in Jun. 2023 was NT$12.6. Eusol Biotech Co's Shares Outstanding (EOP) for the quarter that ended in Jun. 2023 was 137.00 Mil. Therefore, Eusol Biotech Co's market cap for the quarter that ended in Jun. 2023 was NT$1,726.20 Mil.

Eusol Biotech Co's quarterly market cap increased from Jun. 2022 (NT$1,096.00 Mil) to Dec. 2022 (NT$1,126.14 Mil) and increased from Dec. 2022 (NT$1,126.14 Mil) to Jun. 2023 (NT$1,726.20 Mil).

Eusol Biotech Co's annual market cap declined from Dec. 2021 (NT$2,027.60 Mil) to Dec. 2022 (NT$1,126.14 Mil) but then increased from Dec. 2022 (NT$1,126.14 Mil) to Dec. 2023 (NT$1,360.41 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Eusol Biotech Co's Enterprise Value for Today is NT$842.99 Mil.


Eusol Biotech Co Market Cap Historical Data

The historical data trend for Eusol Biotech Co's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Eusol Biotech Co Market Cap Chart

Eusol Biotech Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Market Cap
Get a 7-Day Free Trial Premium Member Only 2,443.75 3,150.00 2,027.60 1,126.14 1,360.41

Eusol Biotech Co Semi-Annual Data
Dec15 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,027.60 1,096.00 1,126.14 1,726.20 1,360.41

Competitive Comparison of Eusol Biotech Co's Market Cap

For the Biotechnology subindustry, Eusol Biotech Co's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Eusol Biotech Co's Market Cap Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Eusol Biotech Co's Market Cap distribution charts can be found below:

* The bar in red indicates where Eusol Biotech Co's Market Cap falls into.



Eusol Biotech Co Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Eusol Biotech Co's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as

Market Cap (A: Dec. 2023 )=Share Price (A: Dec. 2023 )*Shares Outstanding (EOP) (A: Dec. 2023 )
=NT$9.93*137
=NT$1,360.41

Eusol Biotech Co's Market Cap for the quarter that ended in Jun. 2023 is calculated as

Market Cap (Q: Jun. 2023 )=Share Price (Q: Jun. 2023 )*Shares Outstanding (EOP) (Q: Jun. 2023 )
=NT$12.6*137
=NT$1,726.20

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Eusol Biotech Co  (ROCO:6652) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Eusol Biotech Co Market Cap Related Terms

Thank you for viewing the detailed overview of Eusol Biotech Co's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


Eusol Biotech Co (ROCO:6652) Business Description

Traded in Other Exchanges
N/A
Address
Minsheng E. Road, 6th Floor, No.135, Sec.3, Songshan District, Taipei, TWN, 10546
Eusol Biotech Co Ltd is a Taiwan based company that invests in developing new drugs to fulfill unmet medical needs. Its pipeline products include ES135, a recombinant human acidic fibroblast growth factor (rhFGF1) with 135 amino acids; and SM-1, a 3-in-1 capsule containing 3 commercial drugs with the sedative effect.

Eusol Biotech Co (ROCO:6652) Headlines

No Headlines